Addition of COVID Laboratory Results Data to the Sentinel Common Data Model (SCDM) and Establishment of a “Freshest Feasible” Rapid COVID-19 Data Resource

    Basic Details
    Date Posted
    Monday, September 14, 2020
    Status
    In progress
    Health Outcome(s)
    COVID-19
    Description

    This project supports FDA’s COVID-19 response through: 

    1. Adding COVID-19 laboratory results data to the Sentinel Common Data Model (SCDM) for routine querying in the Active Risk Identification and Analysis (ARIA) system
    2. Developing access to the “freshest feasible” rapid COVID-19 data from Sentinel data partners in the distributed data network 
    Information
    Time Period
    January 1, 2018 - Current
    Population / Cohort
    All individuals
    Data Source(s)
    Select Sentinel Data Partners
    Workgroup Leader(s)

    Julie Richard; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

    Workgroup Member(s)

    Judith C. Maro, PhD, MS; Laura Shockro; Christine Halbig, MPH; Daniel Scarnecchia, MPIA; Neesha Nathwani; Tawil Contreras; Linda Curtis; Suzanne Carter, PhD, MS, MBA; Candace Fuller, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA